- Home
- CRON vs SLS Comparison
CRON vs SLS Comparison
Compare CRON & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRON | SLS |
|---|---|---|
| Founded | N/A | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 924.5M |
| IPO Year | 2015 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CRON | SLS |
|---|---|---|
| Price | $3.41 | $14.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 1.4M | ★ 6.3M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $146,587,000.00 | N/A |
| Revenue This Year | $26.34 | N/A |
| Revenue Next Year | $15.53 | $110.98 |
| P/E Ratio | $27.58 | ★ N/A |
| Revenue Growth | ★ 24.63 | N/A |
| 52 Week Low | $2.28 | $1.39 |
| 52 Week High | $3.43 | $15.88 |
Technical Indicators
Market Signals| Indicator | CRON | SLS |
|---|---|---|
| Relative Strength Index (RSI) | 73.28 | 60.91 |
| Support Level | $2.50 | $3.91 |
| Resistance Level | N/A | $15.88 |
| Average True Range (ATR) | 0.12 | 1.07 |
| MACD | 0.03 | 0.31 |
| Stochastic Oscillator | 97.39 | 71.68 |
Price Performance
Historical ComparisonAbout CRON Cronos Group Inc.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.